fda regulations on semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Semaglutide Is Generic for What?

For patients with severe obesity (BMI 40 kg/m or 35 kg/m with comorbidities) who have not achieved adequate weight loss with non-surgical interventions, bariatric surgery may be considered following specialist assessment, as outlined in NICE CG189

Hormonal improvements often occur within 812 weeks as insulin levels drop and androgen production decreases

This can support meaningful weight loss when combined with consistent nutrition habits

Expressed as ratios within that dataset, this is roughly 26-fold preference for MC4R over MC1R, 68-fold over MC5R and 210-fold over MC3R, with no value reported at MC2R, the adrenocorticotropin receptor, which alpha-MSH analogues of this class do not engage